Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Access to care and impacts of cancer on daily life: do they differ for metropolitan versus regional hematological cancer survivors?

Paul CL, Hall AE, Carey ML, Cameron EC, Clinton-McHarg T.

J Rural Health. 2013 Aug;29 Suppl 1:s43-50. doi: 10.1111/jrh.12020. Epub 2013 Mar 25.

PMID:
23944279
2.

Estimating effective population size from linkage disequilibrium between unlinked loci: theory and application to fruit fly outbreak populations.

Sved JA, Cameron EC, Gilchrist AS.

PLoS One. 2013 Jul 23;8(7):e69078. doi: 10.1371/journal.pone.0069078. Print 2013.

3.

Genetic consequences of domestication and mass rearing of pest fruit fly Bactrocera tryoni (Diptera: Tephritidae).

Gilchrist AS, Cameron EC, Sved JA, Meats AW.

J Econ Entomol. 2012 Jun;105(3):1051-6.

PMID:
22812147
4.

Molecular phylogenetics of Aedes japonicus, a disease vector that recently invaded Western Europe, North America, and the Hawaiian islands.

Cameron EC, Wilkerson RC, Mogi M, Miyagi I, Toma T, Kim HC, Fonseca DM.

J Med Entomol. 2010 Jul;47(4):527-35.

PMID:
20695267
5.

Pest fruit fly (Diptera: Tephritidae) in northwestern Australia: one species or two?

Cameron EC, Sved JA, Gilchrist AS.

Bull Entomol Res. 2010 Apr;100(2):197-206. doi: 10.1017/S0007485309990150. Epub 2009 Jul 14.

PMID:
19602297
6.

Effects of handling procedures on pain responses of very low birth weight infants.

Cameron EC, Raingangar V, Khoori N.

Pediatr Phys Ther. 2007 Spring;19(1):40-7.

PMID:
17304096
7.

Comparison of active motor items in infants born preterm and infants born full term.

Cameron EC, Maehle V.

Pediatr Phys Ther. 2006 Fall;18(3):197-203.

PMID:
16912640
8.
9.
11.

Evaluation of the effect of intravenous l-carnitine on quality of life in chronic hemodialysis patients.

Semeniuk J, Shalansky KF, Taylor N, Jastrzebski J, Cameron EC.

Clin Nephrol. 2000 Dec;54(6):470-7.

PMID:
11140808
12.

Cadaver kidney transplantation with minimal delayed function: experience with perioperative strategies to enhance initial renal allograft function.

Shackleton CR, Keown PA, McLoughlin MG, Nigro MK, Meloche RM, Schudamore CH, Manson AD, Kane LM, Smart J, Cameron EC, et al.

Transplant Proc. 1995 Feb;27(1):1075-7. No abstract available.

PMID:
7878811
13.

Magnesium deficiency: pathophysiologic and clinical overview.

al-Ghamdi SM, Cameron EC, Sutton RA.

Am J Kidney Dis. 1994 Nov;24(5):737-52. Review.

PMID:
7977315
14.

Renal microangiopathy in the primary antiphospholipid syndrome: a case report with literature review.

Domrongkitchaiporn S, Cameron EC, Jetha N, Kassen BO, Sutton RA.

Nephron. 1994;68(1):128-32. Review.

PMID:
7991023
15.

Lymphoproliferative disorders after renal transplantation in patients receiving triple or quadruple immunosuppression.

Melosky B, Karim M, Chui A, McBride M, Cameron EC, Yeung CK, Landsberg D, Shackleton C, Keown PA.

J Am Soc Nephrol. 1992 Jun;2(12 Suppl):S290-4. Review.

16.

Renal osteodystrophy: pathophysiology.

Sutton RA, Cameron EC.

Semin Nephrol. 1992 Mar;12(2):91-100. Review. No abstract available.

PMID:
1561500
17.

The quality of initial function following renal transplantation determined by creatinine elimination kinetics. Comparison of Minnesota antilymphocyte globulin and cyclosporine induction immunosuppression.

Shackleton CR, Keown PA, McLoughlin MG, Scudamore CH, Schechter MT, Cameron EC, Yeung CK, Kane LM, Manson AD, Landsberg DN.

Transplantation. 1991 Dec;52(6):1008-13.

PMID:
1750062
18.

Cytomegalovirus epididymitis following renal transplantation.

McCarthy JM, McLoughlin MG, Shackleton CR, Cameron EC, Yeung CK, Jones EC, Keown PA.

J Urol. 1991 Aug;146(2):417-9.

PMID:
1649926
19.

The effect of induction ALG (MALG) on the outcome of steroid-resistant rejection treated with OKT3 in renal transplant patients.

Chiu A, Landsberg D, Cameron EC, Manson AD, Shackleton C.

Transplant Proc. 1991 Feb;23(1 Pt 2):1039-40. No abstract available.

PMID:
1899146
20.

The impact of donor/recipient matching for cytomegalovirus compatibility or identity on the incidence of disease and outcome following renal transplantation.

Shackleton CR, Keown PA, Landsberg DN, McCarthy JM, Scudamore CH, Kane LM, Cameron EC, Yeung CK, Chiu AS.

Transplant Proc. 1991 Feb;23(1 Pt 2):1350-1. No abstract available.

PMID:
1846461
22.

Estimation of aluminoxamine and ferrioxamine in plasma by high performance liquid chromatography.

Hughes H, Hagen LE, Cameron EC, Sutton RA.

Clin Chim Acta. 1986 May 30;157(1):115-20. No abstract available.

PMID:
3719992
23.

In vitro studies using ion exchange resins as potential phosphate binders for renal failure patients.

Burt HM, Cameron EC, Leung M, Erber H, Price JD.

Uremia Invest. 1985-1986;9(1):35-44.

PMID:
3841765
24.

Path analysis in genetic epidemiology: a critique.

Karlin S, Cameron EC, Chakraborty R.

Am J Hum Genet. 1983 Jul;35(4):695-732. Review.

25.

Misconceptions in "Trials of Structured Exploratory Data Analysis".

Karlin S, Cameron EC, Carmelli D, Williams PT.

Am J Hum Genet. 1983 May;35(3):534-40. No abstract available.

26.

The use of dichloromethylene diphosphonate for the management of hypercalcaemia in multiple myeloma.

Paterson AD, Kanis JA, Cameron EC, Douglas DL, Beard DJ, Preston FE, Russell RG.

Br J Haematol. 1983 May;54(1):121-32.

PMID:
6221750
27.

Drug treatment of primary hyperparathyroidism: use of clodronate disodium.

Douglas DL, Kanis JA, Paterson AD, Beard DJ, Cameron EC, Watson ME, Woodhead S, Williams J, Russell RG.

Br Med J (Clin Res Ed). 1983 Feb 19;286(6365):587-90.

28.

Three and a half years experience with CAPD using the Beta Cap technique.

Mavichak V, Moriarty MV, Cameron EC, Reeve CE, Ballon HS, Lauener RW, Price JD.

Trans Am Soc Artif Intern Organs. 1982;28:253-8. No abstract available.

PMID:
7164246
29.

Dialysis encephalopathy and osteomalacic bone disease: a case-controlled study.

Prior JC, Cameron EC, Knickerbocker WJ, Sweeney VP, Suchowersky O.

Am J Med. 1982 Jan;72(1):33-42.

PMID:
7036724
30.

Sibling and parent--offspring correlation estimation with variable family size.

Karlin S, Cameron EC, Williams PT.

Proc Natl Acad Sci U S A. 1981 May;78(5):2664-8.

31.

The role of vitamin D metabolites in the osteomalacia of renal disease.

Kanis JA, Brown CB, Cameron EC, Cundy T, Platts MM, Paterson M, Russell RG.

Curr Med Res Opin. 1981;7(5):294-315. Review.

PMID:
7014108
32.

Biochemical markers of bone turnover in Paget's disease.

Russell RG, Beard DJ, Cameron EC, Douglas DL, Forrest AR, Guilland-Cumming D, Paterson AD, Poser J, Preston CJ, Milford-Ward A, Woodhead S, Kanis JA.

Metab Bone Dis Relat Res. 1981;3(4-5):255-62.

PMID:
6220191
33.
34.
35.

Experience with 1,25-dihydroxycholecalciferol therapy in undergoing hemodialysis patients with progressive vitamin D2-treated osteodystrophy.

Prior JC, Cameron EC, Ballon HS, Lirenman DS, Moriarty MV, Price JD.

Am J Med. 1979 Oct;67(4):583-9.

PMID:
386792
36.

Bone biopsy to diagnose hyperoxaluria in patients with renal failure.

Mathews M, Stauffer M, Cameron EC, Maloney N, Sherrard DJ.

Ann Intern Med. 1979 May;90(5):777-9.

PMID:
434679
37.

Spurious hypocalcemia in hemodialysis patients after heparinization. In-vitro formation of calcium soaps.

Godolphin W, Cameron EC, Frohlich J, Price JD.

Am J Clin Pathol. 1979 Feb;71(2):215-8.

PMID:
425936
38.

A prospective, controlled trial of six forms of hormone replacement therapy given to postmenopausal women.

Lind T, Cameron EC, Hunter WM, Leon C, Moran PF, Oxley A, Gerrard J, Lind UC.

Br J Obstet Gynaecol. 1979;86 Suppl 3:1-29.

PMID:
393299
39.

Cortical thickness measurements and photon absorptiometry for determination of bone quantity.

Cameron EC, Boyd RM, Luk D, McIntosh HW, Walker VR.

Can Med Assoc J. 1977 Jan 22;116(2):145-7.

40.

Brown tumor of the maxilla due to secondary hyperparathyroidism.

Blokmanis A, Cameron EC, Syed AA.

J Otolaryngol. 1976 Oct;5(5):415-20.

PMID:
1033297
41.

New aldehyde dehydrogenase isozymes in chemically induced liver tumors in the rat.

Feinstein RN, Fry RJ, Cameron EC, Peraino C, Morris HP.

Proc Soc Exp Biol Med. 1976 Jul;152(3):463-8. No abstract available.

PMID:
7788
42.

Measurement of bone mineral content in vivo using photon absorptiometry.

Boyd RM, Cameron EC, McIntosh HW, Walker VR.

Can Med Assoc J. 1974 Dec 7;111(11):1201-5.

43.

Aldehyde dehydrogenase activity in a rat hepatoma.

Feinstein RN, Cameron EC.

Biochem Biophys Res Commun. 1972 Sep 5;48(5):1140-6. No abstract available.

PMID:
4341050
44.

A Nonproteolytic "Trypsin-like" Enzyme: Purification and Properties of Arachain.

Cameron EC, Mazelis M.

Plant Physiol. 1971 Sep;48(3):278-81.

45.

Regulation of starch biosynthesis in plant leaves: activation and inhibition of ADPglucose pyrophosphorylase.

Sanwal GG, Greenberg E, Hardie J, Cameron EC, Preiss J.

Plant Physiol. 1968 Mar;43(3):417-27.

46.

PARATHYROID CONTROL OF HYPERCALCEMIA DUE TO INJECTION OF PARATHYROID EXTRACT IN THE RAT.

CAMERON EC, COPP DH.

Proc Soc Exp Biol Med. 1963 Nov;114:278-80. No abstract available.

PMID:
14101164
47.

Evidence for calcitonin--a new hormone from the parathyroid that lowers blood calcium.

COPP DH, CAMERON EC, CHENEY BA, DAVIDSON AG, HENZE KG.

Endocrinology. 1962 May;70:638-49. No abstract available.

PMID:
13881211
48.

Demonstration of a hypocalcemic factor (calcitonin) in commercial parathyroid extract.

COPP DH, CAMERON EC.

Science. 1961 Dec 22;134(3495):2038. No abstract available.

PMID:
13881212

Supplemental Content

Loading ...
Support Center